跳至主要内容
临床试验/NCT01852903
NCT01852903已完成不适用

A Randomized, Double-blind, Placebo-controlled Crossover Study Comparing the Bioavailability of Two Forms of Vitamin C in Plasma and Leukocytes Over 24 Hours.

NBTY, Inc.2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
NBTY, Inc.
入组人数
40
试验地点
2
主要终点
Plasma and leukocyte vitamin C concentration

研究概览

简要总结

The purpose of this study is to compare levels of vitamin C in the blood over the 24 hour period following a single 1000 mg dose of vitamin C from ascorbic acid, calcium ascorbate and placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy as determined by laboratory results and medical history
  • Females not of child bearing potential
  • BMI 18-30 kg/m2
  • Agrees to consume a low vitamin C diet
  • Non-smoker or ex-smoker >1 year

排除标准

  • Pregnant, breastfeeding, or planning to become pregnant during the trial
  • Alcohol >2 drinks per day; alcohol or drug abuse within the past year
  • Cardiac conditions
  • Duodenal ulcer or gastric ulcer, gastritis, hiatus hernia, or gastroesophageal reflux disease (GERD) within past 3 months
  • History irritable bowel syndrome, malabsorption or significant GI disease
  • History of kidney stones
  • Use of medications known to interact with vitamin C
  • Use of supplements containing vitamin C
  • Use of anticoagulants (warfarin), barbiturates, tetracycline antibiotics, beta-blockers, cyclosporine, prednisone, tricyclic antidepressants, diuretics and nitrate medications
  • History of or current diagnosis of cancer
  • Uncontrolled hypertension
  • History of diabetes, renal disease and/or liver disease
  • Unstable psychiatric disorder
  • History of or current immunocompromise
  • History of hemochromatosis or hemoglobinopathies
  • Participation in a clinical research trial <30 days
  • Use of acute medication w/in 72 hours of intervention
  • Unstable medications <90 days
  • Abnormal liver function
  • Serum creatinine > 1.5 x upper limit of normal (ULN)
  • Anemia of any etiology
  • Blood donation w/in the last 2 months
  • Allergy or sensitivity to test articles, foods or beverages provided during the study
  • Cognitive impairment and/or unable to give informed consent

结局指标

主要结局

Plasma and leukocyte vitamin C concentration

时间窗: 0, 2, 4, 8 and 24 hours

次要结局

未报告次要终点

研究者

发起方
NBTY, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验